Lisinopril Market Size Was Valued at USD 1.5 Billion in 2023 and is Projected to Reach USD 2.3 Billion by 2032, Growing at a CAGR of 4.85% From 2024-2032.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart failure. By inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a potent...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian